Skip to Main Content

Editor’s note: A recording of the conversation is embedded below. 

Every week, STAT Plus subscribers get access to exclusive conversations with biotech, pharma and health tech leaders. For this month only, thanks to Allscripts, we’re inviting all STAT readers to join in on these conversations.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!